Legal & General Group PLC Eq Rx, Inc. Transaction History

Legal & General Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.66 - $2.31 $13,316 - $18,530	8,022 Added 4.27%	195,978 $435,000
Q2 2023 Aug 14, 2023	BUY	$1.61 - $1.96 $199,892 - $243,347	124,157 Added 194.61%	187,956 $349,000
Q1 2023 May 15, 2023	BUY	$1.8 - $2.83 $7,786 - $12,242	4,326 Added 7.27%	63,799 $123,000
Q4 2022 Feb 14, 2023	SELL	$2.05 - $5.5 $2,117 - $5,681	-1,033 Reduced 1.71%	59,473 $146,000
Q3 2022 Nov 14, 2022	SELL	$0.94 - $5.99 $7,967 - $50,771	-8,476 Reduced 12.29%	60,506 $299,000
Q2 2022 Aug 22, 2022	BUY	$3.2 - $5.69 $220,742 - $392,507	68,982 New	68,982 $324,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.